Dr. Eric Verdin on the Effects of Therapeutic Plasma Exchange on Longevity episode artwork

EPISODE · Sep 3, 2025 · 52 MIN

Dr. Eric Verdin on the Effects of Therapeutic Plasma Exchange on Longevity

from Longevity by Design · host Gil Blander PhD

In this episode of Longevity by Design, Dr. Gil Blander welcomes Dr. Eric Verdin, President and CEO of the Buck Institute for Research on Aging. Eric discusses the science behind therapeutic plasma exchange (TPE) and its potential to slow biological aging in humans. The conversation explores findings from a recent clinical trial, including measurable age reversal using epigenetic clocks.Eric explains how removing and replacing plasma can dilute pro-aging factors in the blood, a concept inspired by earlier animal studies on parabiosis. He also describes why rigorous, placebo-controlled human trials are crucial for validating longevity interventions and distinguishing the field from hype-driven wellness trends.The episode also highlights how omics data, such as metabolomics and proteomics, are shaping a new era of precision aging research. Eric emphasizes the value of lifestyle interventions as a foundation and sees future opportunities in combining TPE with personalized strategies to extend healthspan.  Guest-at-a-Glance💡 Name: Dr. Eric Verdin💡 What they do: President and CEO💡 Company: Buck Institute for Research on Aging💡 Noteworthy: Physician-scientist pioneering human aging research through epigenetics, metabolism, and translational science.💡 Where to find him: LinkedIn Episode highlights:[00:00] Introduction to Longevity and Healthspan[01:07] Meet Dr. Eric Verde: A Pioneer in Aging Research[02:24] Exploring Therapeutic Plasma Exchange[03:08] The Science Behind Heterochronic Parabiosis[07:17] Clinical Trials and Methodologies[12:58] The Role of Omics in Precision Medicine[17:20] Epigenetic Clocks and Aging[22:04] Therapeutic Plasma Exchange: Results and Implications[26:22] Exploring Frequency and Efficacy of Treatments[28:23] Biomarkers and Predictive Models[31:33] Safety Profile and Side Effects[33:28] Intrinsic Capacity and Aging Metrics[36:58] Combining Treatments with Lifestyle Changes[44:26] Future Directions and Recommendations[49:08] Conclusion and Final ThoughtsWe Appreciate You!As a token of our gratitude, we’re excited to offer you 15% off your next purchase. Simply click the link below to redeem your discount: https://info.insidetracker.com/podcastFor science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast

Episode metadata supplied by the publisher feed · Published Sep 3, 2025

Embed this episode

In this episode of Longevity by Design, Dr. Gil Blander welcomes Dr. Eric Verdin, President and CEO of the Buck Institute for Research on Aging. Eric discusses the science behind therapeutic plasma exchange (TPE) and its potential to slow biological aging in humans. The conversation explores findings from a recent clinical trial, including measurable age reversal using epigenetic clocks. Eric explains how removing and replacing plasma can dilute pro-aging factors in the blood, a concept insp...

Distinct summary based on available episode metadata or transcript content.

Ready to play

Dr. Eric Verdin on the Effects of Therapeutic Plasma Exchange on Longevity

0:00 52:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Longevity by Design?

This episode is 52 minutes long.

When was this Longevity by Design episode published?

This episode was published on September 3, 2025.

Can I download this Longevity by Design episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!